BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20148880)

  • 1. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism.
    Severinsen MT; Overvad K; Johnsen SP; Dethlefsen C; Madsen PH; Tjønneland A; Kristensen SR
    Br J Haematol; 2010 Apr; 149(2):273-9. PubMed ID: 20148880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.
    Delluc A; Le Moigne E; Tromeur C; Noel-Savina E; Couturaud F; Mottier D; Le Gal G; Lacut K
    Br J Haematol; 2011 Aug; 154(4):486-91. PubMed ID: 21671893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
    Holst AG; Jensen G; Prescott E
    Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
    Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
    Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study.
    Lindqvist PG; Epstein E; Olsson H
    Br J Haematol; 2009 Jan; 144(2):234-40. PubMed ID: 19036105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism.
    Shafia S; Zargar MH; Khan N; Ahmad R; Shah ZA; Asimi R
    Gene; 2018 May; 654():1-9. PubMed ID: 29454086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilocus genetic risk scores for venous thromboembolism risk assessment.
    Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
    J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
    Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
    Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
    Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
    Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
    CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.